QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus
12 Junho 2024 - 9:58AM
Business Wire
QHP Capital, L.P. (“QHP”), an investor in technology and
services companies in the life sciences and healthcare sectors,
today announced its sale of Pro-ficiency, LLC (“Pro-ficiency” or
the “Company”), a leader in providing tech-enabled training and
compliance solutions for clinical trial investigators and site
staff, to Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations
Plus”), a leading provider of modeling and simulation software and
services for pharmaceutical safety and efficacy.
Michael Raymer, Chief Executive Officer of Pro-ficiency, said,
“We are excited to join the Simulations Plus team, which has a
well-established and recognized leadership position in modeling and
simulations within the pharmaceutical and biotech community. Both
teams approached this transaction with a growth mentality. We look
forward to leveraging Simulations Plus’ specialized offerings and
business development infrastructure to expand our combined market
reach. Finally, our operations are complementary, our cultures are
aligned, and together we believe we can elevate the performance of
our mutual clients as well as attract new ones with our end-to-end
solutions.”
QHP Capital made its original investment in Pro-ficiency in
2021. The Company then completed several additional acquisitions in
the investment period with Fugitive Labs, LLC in 2022 and Compass
Group Partners in 2023.
“We are very pleased with the growth and innovation we have seen
these past few years at Pro-ficiency. We are excited to see them
continue to improve clinical development as part of the SLP
offering," said Michael Sorensen, Partner at QHP Capital.
About Pro-ficiency:
Pro-ficiency is a leading provider of tech-enabled training and
compliance solutions for clinical trials. The Company provides a
comprehensive suite of services, including a turn-key offering of
customized, virtual training simulations, training and compliance
monitoring tools, and real-time data & predictive analytics.
For more information, please visit www.pro-ficiency.com.
About Simulations Plus, Inc:
Serving clients worldwide for more than 25 years, Simulations
Plus is a leading provider in the biosimulation market providing
software and consulting services supporting drug discovery,
development, research, and regulatory submissions. We offer
solutions that bridge machine learning, physiologically based
pharmacokinetics, quantitative systems pharmacology/toxicology, and
population PK/PD modeling approaches. For more information, please
visit www.simulations-plus.com.
About QHP Capital:
QHP Capital is an investor in technology and services companies
in the life sciences and healthcare sectors. QHP Capital spun out
of NovaQuest Capital Management, which was formed in 2000 with the
vision of building an investment platform to provide strategic
capital and industry expertise in partnership with strong
management teams. The investment team consists of seasoned
investment and operational professionals with significant
investment experience and deep life science and healthcare
expertise. QHP benefits from an extensive network of industry
experts and relationships that assist in identifying, analyzing,
and growing QHP’s portfolio companies. QHP continues as the
investment manager for NovaQuest Private Equity funds. For more
information, please visit www.qhpcapital.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240611617725/en/
For further information about Pro-ficiency, please contact:
Investor Relations Contact: Renee Bouche (661) 723-7723
renee.bouche@simulations-plus.com
For QHP inquiries, please contact: Silvia Cruz (919) 261-5266
silvia.cruz@qhpcapital.com
For media inquiries, please contact: Jeremy Milner BackBay
Communications (401) 862-9422
jeremy.milner@backbaycommunications.com
Simulations Plus (NASDAQ:SLP)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Simulations Plus (NASDAQ:SLP)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024